Download PDF
Thromb Haemost 1974; 32(01): 049-056
DOI: 10.1055/s-0038-1647671
Original Article
Schattauer GmbH

Degradation Products of Fibrinogen and Crosslinked Fibrin—Projected Clinical Applications[*]

Victor J. Marder
1   Department of Medicine and the Specialized Center of Research in Thrombosis, Temple University Health Sciences Center, Philadelphia, Pennsylvania, 19140
,
Andrei Z. Budzynski
1   Department of Medicine and the Specialized Center of Research in Thrombosis, Temple University Health Sciences Center, Philadelphia, Pennsylvania, 19140
› Author Affiliations
Further Information

Publication History

Received for publication 03 June 1974

Accepted for publication 03 June 1974

Publication Date:
30 June 2018 (online)

Also available at
    Permissions and Reprints

 

* Presented at the American Society of Hematology Meeting, Chicago, December 1, 1973.


 

  • References

  • 1 Bell W. R, Pitney W. R, Goodwin J. F. 1968; Therapeutic defibrination in the treatment of thrombotic disease. Lancet 01: 490.
    PubMedGoogle Scholar
  • 2 Blombäck B, Johnson A. J. 1971; Joint report of the subcommittees on nomenclature and on fibrinolysis, thrombolysis, and intravascular coagulation. Thrombosis et Diathesis Haemorrhagica, Suppl 51: 251.
    PubMedGoogle Scholar
  • 3 Btjdzynski A. Z. 1969; Structure of fibrinogen in relation to its proteolytic degradation products. Postepy Higieny i Medycyny Doswiadczalnej 23: 293.
    PubMedGoogle Scholar
  • 4 Btjdzynski A. Z, Stahl M, Kopec M, Latallo Z. S, Wegezynowicz Z, Kowalski E. 1967; High molecular weight products of the late stage of fibrinogen proteolysis by plasmin and their structural relation to the fibrinogen molecule. Biochimica et Biophysica Acta 147: 313.
    CrossrefPubMedGoogle Scholar
  • 5 Budzynski A. Z, Marder V. J, Shainoff J. R. 1974; Structure of plasmic degradation products of human fibrinogen. Fibrinopeptide and polypeptide chain analysis. Journal of Biological Chemistry 249.
    PubMedGoogle Scholar
  • 6 Chen R, Doolittle R. F. 1969; Identification of the polypeptide chains involved in the cross-linking of fibrin. Proceedings of the National Academy of Science USA 63: 420.
    CrossrefPubMedGoogle Scholar
  • 7 Chen R, Doolittle R. F. 1971; y-y cross-linking sites in human and bovine fibrin. Biochemistry 10: 4486.
    CrossrefPubMedGoogle Scholar
  • 8 Dudek G. A, Kloczewiak M, Budzynski A. Z, Latallo Z. S, Kopec M. 1970; Characterization and comparison of macromolecular end products of fibrinogen and fibrin proteolysis by plasmin. Biochimica et Biophysica Acta 214: 44.
    CrossrefPubMedGoogle Scholar
  • 9 Furlan M, Beck E. A. 1972; Plasmic degradation of human fibrinogen. I. Structural characterization of degradation products. Biochimica et Biophysica Acta 263: 631.
    CrossrefPubMedGoogle Scholar
  • 10 Gaffney P. J. 1973; The molecular and functional condition of plasma fibrinogen during thrombolytic therapy with streptokinase (SK). Thrombosis Research 02: 105.
    CrossrefPubMedGoogle Scholar
  • 11 Gaffney P. J, Chesterman C. N, Allington M. J. 1974; Plasma fibrinogen and its fragments during streptokinase treatment. British Journal of Haematology 26: 285.
    CrossrefPubMedGoogle Scholar
  • 12 Kopec M, Teisseyre E, Dudek-Wojciechowska G, Kloczewiak M, Pankiewicz A, Latallo Z. S. 1973; Studies on the “Double D” fragment from stabilized bovine fibrin. Thrombosis Research 02: 283.
    CrossrefPubMedGoogle Scholar
  • 13 Lahiri B, Shainoff J. R. 1973; Fate of fibrinopeptides in the reaction between human plasmin and fibrinogen. Biochimica et Biophysica Acta 303: 161.
    CrossrefPubMedGoogle Scholar
  • 14 Loewy A. G. 1968. Enzymatic control of insoluble-fibrin formation. In: Laki K. (Ed.) Fibrinogen. Marcel Dekker, Inc. New York and Edward Arnold (Publishers, Ltd); London: 185.
    Google Scholar
  • 15 Lorand L, Chenoweth D, Domanik R. A. 1969; Chain pairs in the crosslinking of fibrin. Biochemical and Biophysical Research Communications 37: 219.
    CrossrefPubMedGoogle Scholar
  • 16 Marder Y. J. 1968. Immunologic structure of fibrinogen and its plasmin degradation products. Theoretical and clinical considerations. In: Laki K. (Ed.) Fibrinogen, Marcel Dekker, Inc. New York and Edward Arnold (Publishers, Ltd); London: 339.
    Google Scholar
  • 17 Marder V. J, Budzynski A. Z. 1971; Classification of fibrinogen derivatives. Thrombosis: Risk factors and diagnostic approaches. In: Thrombosis et Diathesis Haemorrhagica Suppl 51: 267.
    PubMedGoogle Scholar
  • 18 Marder V. J, Shulman N. R, Carroll W. R. 1967; The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage. Tranactions of the Association of the American Physicians 80: 156.
    PubMedGoogle Scholar
  • 19 Marder V. J, Shulman N. R, Carroll W. R. 1969; High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. Journal of Biological Chemistry 244: 2111.
    PubMedGoogle Scholar
  • 20 Marder V. J, Budzynski A. Z, James H. L. 1972; High molecular weight derivatives of human fibrinogen produced by plasmin. III. Their N-terminal amino acids and comparison with the “N-terminal disulfide knot.”. Journal of Biological Chemistry 247: 4775.
    PubMedGoogle Scholar
  • 21 McDonagh R. P, McDonagh Jr. J, Blombäck M, Blombäck B. 1971; Crosslinking of human fibrin: Evidence for intermolecular cross-linking involving a-chains. FEBS Letters 14: 33.
    CrossrefPubMedGoogle Scholar
  • 22 McKee P. A, Mattock P, Hill R. L. 1970; Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. Proceedings of the National Academy of Sciences USA 66: 738.
    CrossrefPubMedGoogle Scholar
  • 23 Mills D. A. 1972; Molecular model for the proteolysis of human fibrinogen by plasmin. Biochimica et Biophysica Acta 263: 619.
    CrossrefPubMedGoogle Scholar
  • 24 Mills D, Karpatkin S. 1970; Heterogeneity of human fibrinogen: Possible relation to proteolysis by thrombin and plasmin as studied by SDS-polyacrylamide gel electrophoresis. Biochemical and Biophysical Research Communications 40: 206.
    CrossrefPubMedGoogle Scholar
  • 25 Mills D, Karpatkin S. 1972; The initial macromolecular derivatives of human fibrinogen produced by plasmin. Biochimica et Biophysica Acta 271: 163.
    CrossrefPubMedGoogle Scholar
  • 26 Nossel H. L, Canfield R. E, Butler Jr. V. P. 1973; Plasma fibrinopeptide A concentration as an index of intravascular coagulation. Proceedings of the 4th International Society on Thrombosis and Haemostasis, Vienna 237.
    PubMedGoogle Scholar
  • 27 Nossel H. L, Younger L. R, Wilner G. D, Procuper T, Canfield R. E, Butler Jr. V. P. 1971; Radioimmunoassay of human fibrinopeptide A. Proceedings of the National Academy of Science USA 68: 2350.
    CrossrefPubMedGoogle Scholar
  • 28 Nussenzweig- V, Seligmann M, Pelmont U, Grabar P. 1961; Les produits de degradation du fibrinogène humain par la plasmine. I. Séparation et propriétés physico-chimiques. Annales Institute Pasteur 100: 377.
    PubMedGoogle Scholar
  • 29 Takagi R, Iwanaga S. 1970; Polypeptide chain involved in the cross-linking of stabilized bovine fibrin. Biochemical and Biophysical Research Communications 38: 129.
    CrossrefPubMedGoogle Scholar
  • 30 Takagi R, Iwanaga S. 1970; Polypeptide chain involved in the cross-linking of stabilized bovine fibrin. Biochemical and Biophysical Research Communications 38: 129.
    CrossrefPubMedGoogle Scholar
  • 31 Pizzo S. Y, Taylor Jr. L. M, Schwartz M. L, Hill R. L, McKee P. A. 1973; b Subunit structure of fragment D from fibrinogen and cross-linked fibrin. Journal of Biological Chemistry 248: 4584.
    PubMedGoogle Scholar
  • 32 Robbins K. C. 1944; A study on the conversion of fibrinogen to fibrin. American Journal of Physiology 142: 581.
    PubMedGoogle Scholar
  • 33 Shainoff J. R, Lahiri B, Bumpus F. M. 1970; Ultracentrifuge studies on the reaction between thrombin and plasminized fibrinogen. Thrombosis et Diathesis Haemorrhagica 39: 203.
    PubMedGoogle Scholar
  • 34 Sharp A. A, Warren B. A, Paxton A. M, Allington M. J. 1968; Anticoagulant therapy with a purified fraction of malayan pit viper venom. Lancet 01: 493.
    PubMedGoogle Scholar
  • 35 Takagi R, Iwanaga S. 1970; Polypeptide chain involved in the cross-linking of stabilized bovine fibrin. Biochemical and Biophysical Research Communications 38: 129.
    CrossrefPubMedGoogle Scholar